GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Stryker Corporation (SYK) [hlAlert]

Rating:
Buy SYK
up 41.78 %

Stryker Corporation (SYK) rated Buy with price target $105 by Stifel

Posted on: Wednesday,  Jan 28, 2015  9:25 AM ET by Stifel

Stifel rated Buy Stryker Corporation (NYSE: SYK) on 01/28/2015. Previously Stifel rated Buy Stryker Corporation (NYSE: SYK) on 08/08/2013., when
the stock price was $71.29. Since then, Stryker Corporation has gained 41.79% as of 01/08/2016's recent price of $101.08.
If you would have followed the previous Stifel's recommendation on SYK, you would have gained 41.78% of your investment in 883 days.

Stryker Corporation (Stryker) is a medical technology company with a range of products in orthopaedics and a presence in other medical specialties. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose and throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. The Company operates in two business segments: Orthopaedic Implants and MedSurg Equipment. The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, craniomaxillofacial and spinal implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications and digital imaging systems; as well as patient handling and emergency medical equipment.

Stifel
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2015 9:25 AM Buy
None
92.77 105.00
as of 8/27/2015
1 Week down  -1.40 %
1 Month up  4.61 %
3 Months up  6.10 %
1 YTD up  34.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/8/2013 8:25 AM Buy
None
71.29 81.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy